Association of Inflammatory Cytokines With the Symptom Cluster of Pain, Fatigue, Depression, and Sleep Disturbance in Chinese Patients With Cancer

Journal of Pain and Symptom Management

Volumn 54, Issue 6, 2017, Pages 843-852

  Ji, Yan Bo ^a   Bo, Chun Lu ^a   Xue, Xiu Juan ^a   Weng, En Ming ^b   Gao, Guang Chao ^c   Dai, Bei Bei ^c   Ding, Kai Wen ^d   Xu, Cui Ping ^a  

^a SHANDONG UNIVERSITY   (China)

^b Yanggu No 2 People's Hospital   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

cancer; cluster analysis; cytokine; Symptom cluster

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; CYTOKINE;

ADULT; AGED; ARTICLE; BRIEF FATIGUE INVENTORY; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CHINA; CLINICAL FEATURE; DEPRESSION; DIGESTIVE SYSTEM CANCER; ELECTROCORTICOGRAPHY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUMERIC RATING SCALE; PAIN; PATIENT HEALTH QUESTIONNAIRE 9; PITTSBURGH SLEEP QUALITY INDEX; RURAL POPULATION; SEVERITY OF ILLNESS INDEX; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME; BLOOD; CLUSTER ANALYSIS; IMMUNOLOGY; MIDDLE AGED; NEOPLASM; SOCIOECONOMICS; SYNDROME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CHINA; CLUSTER ANALYSIS; CYTOKINES; DEPRESSION; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SEVERITY OF ILLNESS INDEX; SLEEP WAKE DISORDERS; SOCIOECONOMIC FACTORS; SYNDROME; YOUNG ADULT;

EID: 85030857243     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2017.05.003     Document Type: Article

References (56)

1. Hofman, M., Ryan, J.L., Figueroa-Moseley, C.D., et al. Cancer-related fatigue: the scale of the problem. Oncologist 12 (2007), 4–10.
2. Kvale, E.A., Shuster, J.L., Sleep disturbance in supportive care of cancer: a review. J Palliat Med 9 (2006), 437–450.
3. Mitchell, A.J., Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 25 (2007), 4670–4681.
4. American Pain Society APS. Principles of analgesic use in the treatment of acute pain and cancer pain. 6th ed., 2008, American Pain Society, Glenview.
5. National Comprehensive Cancer Network. Clinical practice guidelines in oncology for adult cancer pain. 2010, National Comprehensive Cancer Network, Fort Washington, 1.
6. Barsevick, A.M., The elusive concept of the symptom cluster. Oncol Nurs Forum 34 (2007), 971–980.
7. Dodd, M.J., Cho, M.H., Cooper, B.A., et al. Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncol Nurs Forum 38 (2011), 33–42.
8. Illi, J., Miaskowski, C., Cooper, B., et al. Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine 58 (2012), 437–447.
9. Miaskowski, C., Cooper, B.A., Paul, S.M., et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes. A cluster analysis. Oncol Nurs Forum 33 (2006), E79–E89.
10. Pud, D., Ben Ami, S., Cooper, B.A., et al. The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. J Pain Symptom Manage 35 (2008), 162–170.
11. Lee, B.N., Dantzer, R., Langley, K.E., et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 11 (2004), 279–292.
12. Miller, A.H., Ancoli-Israel, S., Bower, J.E., Capuron, L., Irwin, M.R., Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26 (2008), 971–982.
13. Capuron, L., Gumnick, J.F., Musselman, D.L., et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26 (2002), 643–652.
14. Dantzer, R., Cytokine-induced sickness behavior. Mechanisms and implications. Ann N Y Acad Sci 933 (2001), 222–234.
15. Konsman, J.P., Parnet, P., Dantzer, R., Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 25 (2002), 154–159.
16. Vollmer-Conna, U., Fazou, C., Cameron, B., et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 34 (2004), 1289–1297.
17. Wang, X.S., Williams, L.A., Krishnan, S., et al. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun 26 (2012), 699–705.
18. Wang, Y.D., Chen, H.S., Shan, Y.J., et al. Cancer-related fatigue in advanced lung cancer patients and its relationship with inflammatory cytokine. Cancer Res Prev Treat (in Chinese) 42 (2015), 576–581.
19. Clevenger, L., Schrepf, A., Christensen, D., et al. Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav Immun 26 (2012), 1037–1044.
20. Sukoff Rizzo, S.J., Neal, S.J., Hughes, Z.A., et al. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl Psychiatry, 2, 2012, e199.
21. Oliveira Miranda, D., Soares de Lima, T.A., Ribeiro Azevedo, L., et al. Proinflammatory cytokines correlate with depression and anxiety in colorectal cancer patients. Biomed Res Int, 2014, 2014, 739650.
22. Wang, X.M., Lehky, T.J., Brell, J.M., Dorsey, S.G., Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine 59 (2012), 3–9.
23. Wang, S.Y., Tsai, C.M., Lin, C.C., Relationship of cytokines to symptom distress and symptom clusters among non-small-cell lung cancer patients receiving gefitinib treatment: a pilot study. J Exp Clin Med 6 (2014), 50–56.
24. Wang, X.S., Shi, Q., Williams, L.A., et al. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun 24 (2010), 968–974.
25. Doong, S.-H., Dhruva, A., Dunn, L.B., et al. Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biol Res Nurs 17 (2015), 237–247.
26. Oken, M.M., Creech, R.H., Tormey, D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982), 649–655.
27. Conill, C., Verger, E., Salamero, M., Performance status assessment in patients with cancer. Cancer 65 (1990), 1864–1866.
28. Wang, X.S., Hao, X.S., Wang, Y., et al. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage 27 (2004), 322–332.
29. Mendoza, T.R., Wang, X.S., Cleeland, C.S., et al. The rapid assessment of fatigue severity in patients with cancer—use of the Brief Fatigue Inventory. Cancer 85 (1999), 1186–1196.
30. Tan, X.-F., Xia, F., Long-term fatigue state in postoperative patients with breast cancer. Chin J Cancer Res 26 (2014), 12–16.
31. Jensen, M.P., The validity and reliability of pain measures in adults with cancer. J Pain 4 (2003), 2–21.
32. Editor Board of Chinese Journal of Behavioral Medical Science. Behavioral medicine scale manual. 2005, Chinese Medical Multimedia Press, Beijing.
33. Hjermstad, M.J., Fayers, P.M., Haugen, D.F., et al. Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 41 (2011), 1073–1093.
34. Yang, P., Sun, L.Q., Lu, Q., Pang, D., Ding, Y., Quality of life in cancer patients with pain in Beijing. Chin J Cancer Res 24 (2012), 60–66.
35. Buysse, D.J., Reynolds, C.F. III, Monk, T.H., Berman, S.R., Kupfer, D.J., The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28 (1989), 193–213.
36. Akman, T., Yavuzsen, T., Sevgen, Z., et al. Evaluation of sleep disorders in cancer patients based on Pittsburgh Sleep Quality Index. Eur J Cancer Care 24 (2015), 553–559.
37. Liu, X.C., Tang, M.Q., Hu, L., et al. Reliability and validity of the Pittsburgh Sleep Quality Index. Chin J Psychiatr 29 (1996), 103–107.
38. Kroenke, K., Spitzer, R.L., Williams, J.B.W., The PHQ-9—validity of a brief depression severity measure. J Gen Intern Med 16 (2001), 606–613.
39. Hinz, A., Mehnert, A., Kocalevent, R.-D., et al. Assessment of depression severity with the PHQ-9 in cancer patients and in the general population. BMC Psychiatry, 16, 2016, 22.
40. Wang, W.Z., Bian, Q., Zhao, Y., et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry 36 (2014), 539–544.
41. Chen, S.L., Chiu, H.L., Xu, B.H., et al. Reliability and validity of the PHQ-9 for screening late-life depression in Chinese primary care. Int J Geriatr Psychiatry 25 (2010), 1127–1133.
42. Dodd, M.J., Cho, M.H., Cooper, B.A., Miaskowski, C., The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs 14 (2010), 101–110.
43. Langford, D.J., Paul, S.M., Cooper, B., et al. Comparison of subgroups of breast patients with cancer on pain and co-occurring symptoms following chemotherapy. Support Care Cancer 24 (2016), 605–614.
44. Kim, H.-J., Barsevick, A.M., Beck, S.L., Dudley, W., Clinical subgroups of a psychoneurologic symptom cluster in women receiving treatment for breast cancer: a secondary analysis. Oncol Nurs Forum 39 (2012), E20–E30.
45. Bower, J.E., Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11 (2014), 597–609.
46. Cleeland, C.S., Bennett, G.J., Dantzer, R., et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 97 (2003), 2919–2925.
47. Reyes-Gibby, C.C., Wu, X., Spitz, M., et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 9 (2008), 777–785.
48. Dantzer, R., Kelley, K.W., Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21 (2007), 153–160.
49. Myers, J.S., Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. Oncol Nurs Forum 35 (2008), 802–807.
50. Tizard, I., Sickness behavior, its mechanisms and significance. Anim Health Res Rev 9 (2008), 87–99.
51. Hong, D.S., Angelo, L.S., Kurzrock, R., Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110 (2007), 1911–1928.
52. Liu, L., Mills, P.J., Rissling, M., et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast patients with cancer undergoing chemotherapy. Brain Behav Immun 26 (2012), 706–713.
53. Bouchard, L.C., Antoni, M.H., Blomberg, B.B., et al. Postsurgical depressive symptoms and proinflammatory cytokine elevations in women undergoing primary treatment for breast cancer. Psychosom Med 78 (2016), 26–37.
54. Tyring, S., Gottlieb, A., Papp, K., et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367 (2006), 29–35.
55. Monk, J.P., Phillips, G., Waite, R., et al. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in patients with cancer. J Clin Oncol 24 (2006), 1852–1859.
56. Kim, H.-J., Abraham, I., Malone, P.S., Analytical methods and issues for symptom cluster research in oncology. Curr Opin Support Palliat Care 7 (2013), 45–53.